Risks associated with Cyclosporine and COVID-19
Cyclosporine is part of immunosuppressive therapy. It is advised to administer Cyclosporine with corticosteroids in organ transplant patients. It increases risk for infection and lymphoma formation. Due to the current COVID-19 pandemic, it is advised to significantly reduce the dose of certain immunosuppressive agents wherein patients who are heart, liver or kidney transplant recipients are exposed to the virus. For outpatients, they can continue the dose as recommended to avoid frequent visits to the doctor [26-27].